Eone Diagnomics Genome Center Co., Ltd.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2013 and listed on KOSDAQ in 2018, EDGC is a genomic big-data company established as a Korea-US joint venture between Korea's Eone Medical Foundation and US-based Diagnomics, Inc. It offers the non-invasive prenatal testing (NIPT) service NICE, the genetic ancestry analysis service YouWho, and the liquid biopsy cancer screening service OncoCatch, using Illumina's Global Screening Array (GSA)-based MGA chip. Health functional food product revenue accounted for 54.43% of sales in the prior fiscal year but fell to 0% in the most recent fiscal year.
Products & technology
- NICENon-invasive prenatal testing (NIPT)
- YouWhoDNA-based genetic ancestry analysis service
- OncoCatchLiquid biopsy-based early cancer detection
Regulatory approvals
data.go.kr8 Korean MFDS device approvals · 2016–2026
- MFDSExtractor, nucleic acid2026-03-24Product approval · Class 1체외 수신 26-628 호
- MFDSIVD reagents for cancer related gene2023-10-24Product approval · Class 3체외 제허 23-1000 호
- MFDSTube, blood collecting, sealed, evacuated2023-06-02Product approval · Class 1제신 23-883 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2022-03-28Product approval · Class 3체외 제허 22-209 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-12-09Product approval · Class 3체외 제허 21-996 호
- MFDSTube, blood collecting, sealed, evacuated2020-03-12Product approval · Class 1수신 20-641 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2017-07-31Product approval · Class 1제신 17-887 호
- MFDSTube, blood collecting, sealed, evacuatedRevoked2016-12-28Product approval · Class 1제신 16-1521 호
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIChatGPT-Useranswer1
- OpenAIOAI-SearchBot4
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 26, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.
Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition